First trimester nuchal translucency: effective routine screening for Down's syndrome.

Area of Science:

• Prenatal diagnosis
• Maternal and fetal health
• Medical imaging

Background:

• Down syndrome is a leading cause of intellectual disability.
• Early detection of fetal chromosomal abnormalities is crucial for informed decision-making.
• Routine ultrasound screening aims to identify pregnancies at increased risk.

Purpose of the Study:

• To assess the efficacy of nuchal translucency (NT) measurement at 10-14 weeks gestation.
• To determine the detection rate of Down syndrome and other aneuploidies using NT screening.
• To establish an optimal screening protocol for first-trimester fetal aneuploidy detection.

Main Methods:

• A prospective study involving 11,398 pregnant women.
• Nuchal translucency measurements were performed between 10 and 14 weeks of gestation.
• A risk threshold of >= 1:200 was applied to achieve a 5% screen-positive rate.

Main Results:

• The study achieved a 5% screen-positive rate.
• First-trimester screening detected 76% of Down syndrome cases (16/21).
• Eighty-one percent (40/49) of aneuploid fetuses were identified.

Conclusions:

• First-trimester nuchal translucency measurement is a reliable screening method.
• This technique enables early detection of fetal chromosomal abnormalities.
• NT screening offers significant potential for improving prenatal care.